Enabling a Healthier World

At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Working across five continents, our global community of around 18,000 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market.

United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.

Read more

Lonza’s stock
(LONN.SW: SIX Swiss Ex)
Last price:
CHF 502.00
Change today:
15.60 (%-3.01)